Basem M. William
0000-0001-8090-4605
Publication & Citation Trends
Most Cited Works
Publications
238 total
Axicabtagene ciloleucel in relapsed or refractory indolent non-Hodgkin lymphoma (ZUMA-5): a single-arm, multicentre, phase 2 trial
Cited by 597
OpenAlex
Primary Analysis of Zuma-5: A Phase 2 Study of Axicabtagene Ciloleucel (Axi-Cel) in Patients with Relapsed/Refractory (R/R) Indolent Non-Hodgkin Lymphoma (iNHL)
Cited by 107
OpenAlex
Clinical activity of axicabtagene ciloleucel in adult patients with Richter syndrome PDF
Cited by 70
OpenAlex
IPH4102, a first-in-class anti-KIR3DL2 monoclonal antibody, in patients with relapsed or refractory cutaneous T-cell lymphoma: an international, first-in-human, open-label, phase 1 trial PDF
Cited by 156
OpenAlex
Mogamulizumab versus vorinostat in previously treated cutaneous T-cell lymphoma (MAVORIC): an international, open-label, randomised, controlled phase 3 trial PDF
Cited by 636
OpenAlex
CC-486 Maintenance after Stem Cell Transplantation in Patients with Acute Myeloid Leukemia or Myelodysplastic Syndromes PDF
Cited by 148
OpenAlex
Research Topics
Lymphoma Diagnosis and Treatment
(95)
CAR-T cell therapy research
(77)
Hematopoietic Stem Cell Transplantation
(46)
T-cell and Retrovirus Studies
(39)
Cutaneous lymphoproliferative disorders research
(37)
Frequent Co-Authors
Affiliations
Ain Shams University
OhioHealth
Nebraska Medical Center
Memorial Sloan Kettering Cancer Center
University Hospitals of Cleveland